Researchers at Stanford University and Texas A&M University have synthesized highly sensitive class A Beta-lactamase-specific fluorogenic probes that could enable the development of a fast and simple point-of-care diagnostic for tuberculosis. Global BioDiagnostics has in-licensed the technology.